Regulatory Roundup: US Pharmacopeia Seeks Scientists For Its 2011-2012 Fellowship Program - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Regulatory Roundup: US Pharmacopeia Seeks Scientists For Its 2011-2012 Fellowship Program

ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Pharmacopeia (USP) is seeking scientists from around the world for its 2011-2012 fellowship program. The two $50,000 research fellowship awards will be presented to the students whose proposed research best directly addresses specific USP scientific or research needs, according to a USP notice on the program. The deadline for submissions is May 20, 2011. Full details are online at www.usp.org/aboutUSP/careers/fellowship.html.

In addition to the implementation training programs ICH has been conducting around the world during the past year, the organization is now posting on its website a consolidated training package. This package covers the integrated implementation of the ICH Q8, Q9, and Q10 guidelines including details on technical development, manufacturing , pharmaceutical quality systems, and regulatory expectations (e.g., dossier preparation, assessment, and GMP-inspections), according to an ICH press release.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here